These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23015721)

  • 21. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.
    Carlson JM; Brumme ZL; Rousseau CM; Brumme CJ; Matthews P; Kadie C; Mullins JI; Walker BD; Harrigan PR; Goulder PJ; Heckerman D
    PLoS Comput Biol; 2008 Nov; 4(11):e1000225. PubMed ID: 19023406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping.
    Robinson LH; Gale CV; Kleim JP
    J Virol Methods; 2002 Jul; 104(2):147-60. PubMed ID: 12088824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda.
    Yirrell DL; Kaleebu P; Morgan D; Watera C; Magambo B; Lyagoba F; Whitworth J
    AIDS; 2002 Jan; 16(2):279-86. PubMed ID: 11807313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region.
    Renjifo B; Gilbert P; Chaplin B; Vannberg F; Mwakagile D; Msamanga G; Hunter D; Fawzi W; Essex M
    AIDS; 1999 Sep; 13(13):1613-21. PubMed ID: 10509561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
    Brumme ZL; Li C; Miura T; Sela J; Rosato PC; Brumme CJ; Markle TJ; Martin E; Block BL; Trocha A; Kadie CM; Allen TM; Pereyra F; Heckerman D; Walker BD; Brockman MA
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):100-8. PubMed ID: 21124229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
    Crawford H; Lumm W; Leslie A; Schaefer M; Boeras D; Prado JG; Tang J; Farmer P; Ndung'u T; Lakhi S; Gilmour J; Goepfert P; Walker BD; Kaslow R; Mulenga J; Allen S; Goulder PJ; Hunter E
    J Exp Med; 2009 Apr; 206(4):909-21. PubMed ID: 19307327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant.
    Schneidewind A; Tang Y; Brockman MA; Ryland EG; Dunkley-Thompson J; Steel-Duncan JC; St John MA; Conrad JA; Kalams SA; Noel F; Allen TM; Christie CD; Feeney ME
    J Virol; 2009 Sep; 83(17):8616-27. PubMed ID: 19515764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
    AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses.
    Claiborne DT; Prince JL; Hunter E
    J Vis Exp; 2014 Aug; (90):. PubMed ID: 25225725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.
    Gao F; Robertson DL; Morrison SG; Hui H; Craig S; Decker J; Fultz PN; Girard M; Shaw GM; Hahn BH; Sharp PM
    J Virol; 1996 Oct; 70(10):7013-29. PubMed ID: 8794346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.
    Boutwell CL; Carlson JM; Lin TH; Seese A; Power KA; Peng J; Tang Y; Brumme ZL; Heckerman D; Schneidewind A; Allen TM
    J Virol; 2013 Apr; 87(7):3952-65. PubMed ID: 23365420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p24 of B- and C-subtypes.
    Gupta S; Arora K; Gupta A; Chaudhary VK
    Protein Expr Purif; 2000 Aug; 19(3):321-8. PubMed ID: 10910720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss.
    Dam E; Quercia R; Glass B; Descamps D; Launay O; Duval X; Kräusslich HG; Hance AJ; Clavel F;
    PLoS Pathog; 2009 Mar; 5(3):e1000345. PubMed ID: 19300491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization.
    Cornelissen M; Kampinga G; Zorgdrager F; Goudsmit J
    J Virol; 1996 Nov; 70(11):8209-12. PubMed ID: 8892955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 replicative fitness in elite controllers.
    Lobritz MA; Lassen KG; Arts EJ
    Curr Opin HIV AIDS; 2011 May; 6(3):214-20. PubMed ID: 21430530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.
    Prince JL; Claiborne DT; Carlson JM; Schaefer M; Yu T; Lahki S; Prentice HA; Yue L; Vishwanathan SA; Kilembe W; Goepfert P; Price MA; Gilmour J; Mulenga J; Farmer P; Derdeyn CA; Tang J; Heckerman D; Kaslow RA; Allen SA; Hunter E
    PLoS Pathog; 2012; 8(11):e1003041. PubMed ID: 23209412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.